Safety and efficacy of an additive consisting of Bacillus amyloliquefaciens DSM 25840 for all animal species (Chr. Hansen A/S)

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the additive consisting of Bacillus amyloliquefaciens DSM 25840 when used as technological additive (hygiene condition enhancer) in feed for all animal species. The product is intended for use in dry feeds at a minimum inclusion level of 1 × 10⁸ colony forming unit (CFU)/kg complete feedingstuffs. The bacterial species Bacillus amyloliquefaciens DSM 25840 is considered by EFSA to be eligible for the qualified presumption of safety approach. As the identity of the strain has been clearly established and it did not show acquired resistance to antibiotics of human and veterinary importance, the use of the strain in animal nutrition is considered safe for the target species, consumers and the environment. No conclusions can be drawn on the skin/eye irritancy or skin sensitisation potential of the product. Exposure of users by inhalation is likely and the product should be considered a respiratory sensitiser. The Panel is not in the position to conclude on the efficacy of Bacillus amyloliquefaciens DSM 25840 when used in animal nutrition as hygiene condition enhancer due to lack of data. Bacillus amyloliquefaciens DSM 25840 is compatible with diclazuril, decoquinate and halofuginone. The data provided do not allow to conclude on the compatibility of the additive with monensin sodium, salinomycin sodium, narasin, robenidine hydrochloride and maduramicin ammonium.

1. Introduction

1.1. Background and Terms of Reference as provided by the requestor

Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7.

The European Commission received a request from Chr. Hansen A/S2 for authorisation of the product Bacillus amyloliquefaciens DSM 25840, when used as a feed additive for all animal species, (category: technological additive; functional group: hygiene condition enhancer).

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive). The particulars and documents in support of the application were considered valid by EFSA as of 15 December 2017.

According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product Bacillus amyloliquefaciens DSM 25840, when used under the proposed conditions of use (see Section 3.1.4).

1.2. Additional information

The product under assessment is based on viable spores of Bacillus amyloliquefaciens DSM 25840. The active agent is currently authorised as a feed additive (category: zootechnical additive) for all porcine species in the European Union.

The microorganism Bacillus amyloliquefaciens DSM 25840 is also authorised as a feed additive in the European Union as part of a zootechnical additive composed of Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325 and Bacillus amyloliquefaciens DSM 25840.

EFSA delivered one opinion on the safety and efficacy and one on the efficacy of Bacillus amyloliquefaciens DSM 25840 as a zootechnical additive for piglets and minor porcine species (EFSA FEEDAP Panel, 2018a,b, 2019). In addition, EFSA delivered an opinion on the safety and efficacy of the microorganism B. subtilis DSM 32324 as part of the additive GalliPro^® Fit (Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325 and Bacillus amyloliquefaciens DSM 25840) (EFSA FEEDAP Panel, 2020).

2. Data and methodologies

2.1. Data

The present assessment is based on data submitted by the applicant in the form of a technical dossier3 in support of the authorisation request for the use of Bacillus amyloliquefaciens DSM 25840 as a feed additive.

The European Union Reference Laboratory (EURL) considered that the conclusions and recommendations reached in the previous assessment regarding the methods used for the control of the active agent in animal feed are valid and applicable for the current application.4

2.2. Methodologies

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of Bacillus amyloliquefaciens DSM 25840 is in line with the principles laid down in Regulation (EC) No 429/20085 and the relevant guidance documents: Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012), Guidance on the identity, characterisation and conditions of use of feed additives (EFSA FEEDAP Panel, 2017a), Guidance on the characterisation of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018a,b, 2019), Guidance on the assessment of the safety of feed additives for the target species (EFSA FEEDAP Panel, 2017b), Guidance on the assessment of the safety of feed additives for the consumer (EFSA FEEDAP Panel, 2017c), Guidance on the assessment of the efficacy of feed additives (EFSA FEEDAP Panel, 2018a,b, 2019), Guidance on the assessment of the safety of feed additives for the environment (EFSA FEEDAP Panel, 2019).

3. Assessment

The additive is composed of spores of Bacillus amyloliquefaciens DSM 25840 and is intended to be used as a technological additive (functional group: hygiene condition enhancer) in feed for all animal species. The applicant states that the additive improves hygienic characteristics of the feed by reducing the microbiological contamination by Escherichia coli.

3.1. Characterisation

3.1.1. Characterisation of the active agent

Bacillus amyloliquefaciens DSM 25840 was isolated from faeces of a healthy adult pig in Germany. It is deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen with the accession number DSM 25840.6 ■■■■■7 The strain has not been genetically modified.

Taxonomic identification of strain DSM 25840 as Bacillus amyloliquefaciens was established by bioinformatic analysis of the whole genome sequences (WGS).8 This was based on multi‐locus sequence analysis (16S rRNA gene and partial groEL, gyrA, polC, purH and rpoB gene sequences) and average nucleotide identity (ANI). The ANI value obtained from the comparison with the type strain (NCTC 3610^T) genome based on MUMmer (ANIm) was 99.5%.9

The toxigenic potential of the strain was assessed according to the Guidance on the characterisation of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018a,b, 2019). No lysis of Vero cells was detected. Therefore, Bacillus amyloliquefaciens DSM 25840 is considered to be non‐toxigenic.10

The susceptibility of the strain to the antimicrobials recommended by the FEEDAP Panel was tested ■■■■■ according to the Clinical and Laboratory Standards Institute (CLSI) and all of the minimum inhibitory concentration (MIC) values determined fell below the FEEDAP cut‐off values (EFSA FEEDAP Panel, 2018a,b, 2019).11 The WGS of the active agent was interrogated for the presence of antimicrobial resistance genes (AMR) ■■■■■12 No relevant hits were identified.

3.1.2. Characterisation of the additive

■■■■■

Compliance with the guaranteed minimum total concentration of viable spores of B. amyloliquefaciens DSM 25840 in the product of 1.3 × 10¹⁰ CFU/g additive was demonstrated in five batches of the additive (1.61 × 10¹⁰ CFU/g additive, range 1.60–1.64 × 10¹⁰ CFU/g additive).14

Three batches of the additive were analysed for chemical contamination (lead (0.301–0.336 mg/kg; cadmium (0.086 mg/kg in all three batches); mercury (0.0093–0.0110 mg/kg); arsenic (0.628–0.896 mg/kg)), dioxins (< 0.186 WHO‐PCDD/F‐TEQ ng/kg), dioxins like PCBs (< 0.198 WHO‐PCDD/F‐PCB‐TEQ ng/kg) and aflatoxin B1 (˂ LOQ) and they were in compliance with the maximum levels specified.15 Analysis of microbial contamination in five batches indicated that Bacillus cereus, coliforms and yeasts and moulds were < 10³ CFU/g, Escherichia coli was < 10 CFU/g, while Salmonella spp. was absent in 25 g.14 Chemical and microbiological analyses did not raise any concern.

The additive is a slightly hygroscopic, free‐flowing powder with a white to yellowish colour. The dusting potential of the additive was measured in three batches following the Stauber‐Heubach method and the mean value was 13.5 g/m³ (range of 11.2–17.0 g/m³).16 The particle size was measured in the same batches using laser diffraction, particles below 100 μm amounted up to 12.3% (v/v), particles below 10 μm amounted up to 4.3%.17

3.1.3. Stability and homogeneity

The shelf‐life of the additive was determined by monitoring three batches stored at 25°C, 30°C and 37°C for a period of 12 months.18 Negligible losses (< 0.5 Log difference) were observed after 12 months.

Three batches of the additive were individually mixed into a mineral premixture for piglets at a concentration of 1.7 × 10⁷ CFU/g premixture and samples were stored for 6 months at 20–25°C.19 Negligible losses (< 0.5 Log difference) were observed after 6 months.

Stability in complete feed was investigated using three batches of the additive incorporated into a typical mash feed for chickens (corn and soya) and into a pelleted feed of the same composition (pelleting conditions 95°C) at the intended concentration of 1.0 × 10⁸ CFU/kg feed.20 Samples of the mash and pelleted feed were stored for up to 6 months at 20–25°C. The results showed that negligible losses (< 0.5 Log difference) occurred in both mash and pelleted feed.

The stability studies of the additive during pelleting of a standard piglet feed (pelleting temperature: 75, 85 and 95°C) showed a negligible loss of bacilli (< 0.5 Log difference).21

A total of 10 subsamples were taken from the pelleted feed and analysed for total bacilli counts and the coefficient of variation was 5.2%.22

3.1.4. Conditions of use

The product is intended to be used as a technological additive (functional group: hygiene condition enhancer) in dry feed for all animal species, alone or in combination with other hygiene condition enhancer strains, at a minimum inclusion level of 1.0 × 10⁸ CFU/kg complete feedingstuffs. The applicant requests for the simultaneous use of the additive with the following coccidiostats: decoquinate, diclazuril, halofuginone, monensin sodium, maduramicin ammonium, narasin, robenidine and salinomycin sodium.

3.2. Safety

3.2.1. Safety for the target species, the consumer and the environment

The strain B. amyloliquefaciens DSM 25840 belongs to a species considered to qualify for the qualified presumption of safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2020). This approach requires the identity of the strain to be conclusively established and evidence that the strain does not show acquired resistance to antibiotics of human and veterinary importance and lack of toxigenic potential. The identity of the strain has been unambiguously established. Evidence was provided on the lack of toxigenic potential of the strain and on the absence of acquired antimicrobial resistance genes. Therefore, the FEEDAP Panel concludes that the additive does not raise safety concerns for the target species, consumers of products derived from animals fed the additive and the environment.

3.2.2. Safety for user

No studies, other than those relating to dust formation, were provided by the applicant on the safety of the additive for users. Therefore, no conclusions can be drawn on the skin/eye irritancy or skin sensitisation of the additive.

The high dusting potential (up to 17.0 g/m³) indicates that exposure by inhalation is likely to occur. Due to the proteinaceous nature of the active agents, the additive should be considered a respiratory sensitiser.

3.3. Efficacy

3.3.1. Efficacy in feedingstuffs

The additive is intended to improve the hygienic characteristics of the feed by reducing the microbiological contamination by Escherichia coli.

To prove the effects as a hygiene condition enhancer, an in vitro study ■■■■■ was conducted.23 ■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■

The Panel notes the following limitations in the study design■■■■■ These limitations prevent the assessment of the efficacy of the additive under practical use conditions to be done.

3.3.2. Compatibility with coccidiostats

The compatibility of B. amyloliquefaciens DSM 25840, with diclazuril, decoquinate and halofuginone, monensin sodium, salinomycin sodium, narasin, robenidine hydrochloride and maduramicin ammonium27 was assessed in the context of a previous application (EFSA FEEDAP Panel, 2020) The Panel concluded that B. amyloliquefaciens DSM 25840 is compatible with diclazuril, decoquinate and halofuginone. The data provided do not allow to conclude on the compatibility of the additive with monensin sodium, salinomycin sodium, narasin, robenidine hydrochloride and maduramicin ammonium. The same information was submitted in the present application and therefore, the same conclusions apply.

3.3.3. Conclusions on efficacy

In the absence of valid studies, the Panel cannot conclude on the efficacy of Bacillus amyloliquefaciens DSM 25840 as hygiene condition enhancer.

Bacillus amyloliquefaciens DSM 25840 is compatible with diclazuril, decoquinate and halofuginone. The data provided do not allow to conclude on the compatibility of the additive with monensin sodium, salinomycin sodium, narasin, robenidine hydrochloride and maduramicin ammonium.

3.4. Post‐market monitoring

The FEEDAP Panel considers that there is no need for specific requirements for a post‐market monitoring plan other than those established in the Feed Hygiene Regulation28 and Good Manufacturing Practice.

4. Conclusions

Based on the QPS approach to safety assessment, B. amyloliquefaciens DSM 25840 is presumed safe for the target species, consumers of products from animals fed the additive and the environment.

Due to the absence of data, no conclusions can be drawn on the skin/eye irritancy or skin sensitisation of the product under assessment. Given the proteinaceous nature of the active agent, B. amyloliquefaciens DSM 25840 should be considered a respiratory sensitiser. Exposure of users by inhalation is likely.

In the absence of valid studies investigating relevant and specific endpoints, no conclusion can be drawn on the efficacy of B. amyloliquefaciens DSM 25840 as hygiene condition enhancer. Bacillus amyloliquefaciens DSM 25840 is compatible with diclazuril, decoquinate and halofuginone. The data provided do not allow to conclude on the compatibility of the additive with monensin sodium, salinomycin sodium, narasin, robenidine hydrochloride and maduramicin ammonium.

5. Documentation as provided to EFSA/Chronology

Date	Event
19/10/2017	Dossier received by EFSA. Bacillus amyloliquefaciens DSM 25840 for all animal species. Submitted by Chr. Hansen A/S.
03/11/2017	Reception mandate from the European Commission
15/12/2017	Application validated by EFSA – Start of the scientific assessment
16/03/2018	Comments received from Member States
17/06/2020	Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 – Scientific assessment suspended. Issues: characterisation of the additive; characterisation of the strain; purity of the additive
27/08/2020	Reception of supplementary information from the applicant ‐ Scientific assessment re‐started
17/03/2021	Opinion adopted by the FEEDAP Panel. End of the Scientific assessment

Abbreviations

AMR

antimicrobial resistance genes

ANI

average nucleotide identity

BIOHAZ

EFSA Panel on Biological Hazards

CFU

colony forming unit

CLSI

Clinical and Laboratory Standards Institute

EURL

European Union Reference Laboratory

FEEDAP

EFSA Panel on Additives and Products or Substances used in Animal Feed

LOQ

limit of quantification

MIC

minimum inhibitory concentration

QPS

Qualified Presumption of Safety

WHO

World Health Organization

Suggested citation: EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed) , Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Fašmon Durjava M, Kouba M, López‐Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Brozzi R, Galobart J, Pettenati E, Revez J and Innocenti ML, 2021. Scientific Opinion on the safety and efficacy of an additive consisting of Bacillus amyloliquefaciens DSM 25840 for all animal species (Chr. Hansen A/S). EFSA Journal 2021;19(4):6522, 9 pp. 10.2903/j.efsa.2021.6522